HEARTBEAM, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HEARTBEAM, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $10.00K.
- HEARTBEAM, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $1.00K, a 95.24% decline year-over-year.
- HEARTBEAM, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- HEARTBEAM, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $0.00.
- HEARTBEAM, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $13.00K, a 90.44% decline from fiscal 2024.
- HEARTBEAM, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $136.00K, a 36.45% decline from fiscal 2023.
- HEARTBEAM, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $214.00K, a 10600.00% increase from fiscal 2022.
- HEARTBEAM, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $2.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $10.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $13.00K 10-K · filed 2026-03-12 | |
| 2025-09-30 | $1.00K 10-Q · filed 2025-11-13 | $108.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $128.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | $136.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $136.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $21.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $8.00K 10-Q · filed 2025-08-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $214.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | $111.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $103.00K 10-Q · filed 2024-08-14 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $2.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | |
| 2022-06-30 | $2.00K 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |